Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Oramorph 10mg/5ml oral solution
0407020Q0BCAGCN
|
Oramorph | Morphine sulfate | Central Nervous System | 131,651 |
|
Oramorph 20mg/ml concentrated oral solution
0407020Q0BCABA6
|
Oramorph | Morphine sulfate | Central Nervous System | 894 |
|
Oramorph 100mg/5ml oral solution unit dose vials
0407020Q0BCAJCU
|
Oramorph | Morphine sulfate | Central Nervous System | No data available |
|
Oramorph 10mg/5ml oral solution unit dose vials
0407020Q0BCAHGB
|
Oramorph | Morphine sulfate | Central Nervous System | No data available |
|
Oramorph 30mg/5ml oral solution unit dose vials
0407020Q0BCAICT
|
Oramorph | Morphine sulfate | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.